-
1
-
-
0002694436
-
The epidemiology and natural history of herpes zoster and postherpetic neuralgia
-
Watson C.P.N. (Ed), Elsevier, Amsterdam
-
Dworkin R.H., and Schmader K.E. The epidemiology and natural history of herpes zoster and postherpetic neuralgia. In: Watson C.P.N. (Ed). Herpes zoster and postherpetic neuralgia. 2nd ed (2001), Elsevier, Amsterdam 39-65
-
(2001)
Herpes zoster and postherpetic neuralgia. 2nd ed
, pp. 39-65
-
-
Dworkin, R.H.1
Schmader, K.E.2
-
3
-
-
33646586688
-
Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction
-
Flatters S.J., and Bennett G.J. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 122 (2006) 245-257
-
(2006)
Pain
, vol.122
, pp. 245-257
-
-
Flatters, S.J.1
Bennett, G.J.2
-
4
-
-
33746665258
-
Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the rat
-
Jimenez-Andrade J.M., Peters C.M., Mejia N.A., et al. Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the rat. Neurosci Lett 405 (2006) 62-67
-
(2006)
Neurosci Lett
, vol.405
, pp. 62-67
-
-
Jimenez-Andrade, J.M.1
Peters, C.M.2
Mejia, N.A.3
-
5
-
-
32244438054
-
Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy
-
Hausheer F.H., Schilsky R.L., Bain S., et al. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 33 (2006) 15-49
-
(2006)
Semin Oncol
, vol.33
, pp. 15-49
-
-
Hausheer, F.H.1
Schilsky, R.L.2
Bain, S.3
-
6
-
-
0041386046
-
Development of a Neuropathic Pain Questionnaire
-
Krause S.J., and Backonja M.-M. Development of a Neuropathic Pain Questionnaire. Clin J Pain 19 (2003) 306-314
-
(2003)
Clin J Pain
, vol.19
, pp. 306-314
-
-
Krause, S.J.1
Backonja, M.-M.2
-
7
-
-
0043073211
-
Measuring the side effects of taxane therapy in oncology: the functional assessment of cancer therapy-taxane (FACT-taxane)
-
Cella D., Peterman A., Hudgens S., Webster K., and Socinski M.A. Measuring the side effects of taxane therapy in oncology: the functional assessment of cancer therapy-taxane (FACT-taxane). Cancer 98 (2003) 822-831
-
(2003)
Cancer
, vol.98
, pp. 822-831
-
-
Cella, D.1
Peterman, A.2
Hudgens, S.3
Webster, K.4
Socinski, M.A.5
-
8
-
-
21144457498
-
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20
-
Postma T.J., Aaronson N.K., Heimans J.J., et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 41 (2005) 1135-1139
-
(2005)
Eur J Cancer
, vol.41
, pp. 1135-1139
-
-
Postma, T.J.1
Aaronson, N.K.2
Heimans, J.J.3
-
9
-
-
0031823939
-
Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy
-
Postma T.J., Heimans J.J., Muller M.J., et al. Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy. Ann Oncol 9 (1998) 739-744
-
(1998)
Ann Oncol
, vol.9
, pp. 739-744
-
-
Postma, T.J.1
Heimans, J.J.2
Muller, M.J.3
-
10
-
-
0028270476
-
Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies
-
Chaudhry V., Rowinsky E.K., Sartorius S.E., et al. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 35 (1994) 304-311
-
(1994)
Ann Neurol
, vol.35
, pp. 304-311
-
-
Chaudhry, V.1
Rowinsky, E.K.2
Sartorius, S.E.3
-
11
-
-
0030839691
-
Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing
-
Forsyth P.A., Balmaceda C., Peterson K., et al. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neurooncol 35 (1997) 47-53
-
(1997)
J Neurooncol
, vol.35
, pp. 47-53
-
-
Forsyth, P.A.1
Balmaceda, C.2
Peterson, K.3
-
12
-
-
1842735565
-
Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients
-
Dougherty P.M., Cata J.P., Cordella J.V., et al. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109 (2004) 132-142
-
(2004)
Pain
, vol.109
, pp. 132-142
-
-
Dougherty, P.M.1
Cata, J.P.2
Cordella, J.V.3
-
13
-
-
22844448647
-
Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?
-
Argyriou A.A., Polychronopoulos P., Koutras A., et al. Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?. Support Care Cancer 13 (2005) 647-651
-
(2005)
Support Care Cancer
, vol.13
, pp. 647-651
-
-
Argyriou, A.A.1
Polychronopoulos, P.2
Koutras, A.3
-
14
-
-
33644980892
-
Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy
-
Flatters S.J., Xiao W.H., and Bennett G.J. Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neurosci Lett 397 (2006) 219-223
-
(2006)
Neurosci Lett
, vol.397
, pp. 219-223
-
-
Flatters, S.J.1
Xiao, W.H.2
Bennett, G.J.3
-
15
-
-
0024513342
-
Effects of L-carnitine, L-acetylcarnitine and gangliosides on the regeneration of the transected sciatic nerve in rats
-
Fernandez E., Pallini R., Gangitano C., et al. Effects of L-carnitine, L-acetylcarnitine and gangliosides on the regeneration of the transected sciatic nerve in rats. Neurol Res 11 (1989) 57-62
-
(1989)
Neurol Res
, vol.11
, pp. 57-62
-
-
Fernandez, E.1
Pallini, R.2
Gangitano, C.3
-
16
-
-
1842786064
-
Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy
-
Flatters S.J., and Bennett G.J. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 109 (2004) 150-161
-
(2004)
Pain
, vol.109
, pp. 150-161
-
-
Flatters, S.J.1
Bennett, G.J.2
-
17
-
-
45949131693
-
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies
-
Wolf S., Barton D., Kottschade L., et al. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 44 (2008) 1507-1515
-
(2008)
Eur J Cancer
, vol.44
, pp. 1507-1515
-
-
Wolf, S.1
Barton, D.2
Kottschade, L.3
-
18
-
-
0037366026
-
Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy
-
Pace A., Savarese A., Picardo M., et al. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol 21 (2003) 927-931
-
(2003)
J Clin Oncol
, vol.21
, pp. 927-931
-
-
Pace, A.1
Savarese, A.2
Picardo, M.3
-
19
-
-
33845454129
-
A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results
-
Argyriou A.A., Chroni E., Koutras A., et al. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results. Support Care Cancer 14 (2006) 1134-1140
-
(2006)
Support Care Cancer
, vol.14
, pp. 1134-1140
-
-
Argyriou, A.A.1
Chroni, E.2
Koutras, A.3
-
20
-
-
46049107024
-
Vitamin E in the neuroprotection of cisplatin induced peripheral neurotoxicity and ototoxicity [abstr 9114]
-
(18S)
-
Pace A., Carpano S., Galie E., et al. Vitamin E in the neuroprotection of cisplatin induced peripheral neurotoxicity and ototoxicity [abstr 9114]. J Clin Oncol (2007) 25 (18S)
-
(2007)
J Clin Oncol
, pp. 25
-
-
Pace, A.1
Carpano, S.2
Galie, E.3
-
21
-
-
65549171128
-
A phase III randomized, placebo-controlled, double-blind sutdy of intravenous calcium/magnesium to prevent oxaliplatin-induced sensory neurotoxicity, N04C7
-
Nikcevich DA, Grothey A, Sloan JA, et al. A phase III randomized, placebo-controlled, double-blind sutdy of intravenous calcium/magnesium to prevent oxaliplatin-induced sensory neurotoxicity, N04C7. J Clin Oncol 2008 ASCO Annual Meeting Proceedings (Abstract 280).
-
J Clin Oncol 2008 ASCO Annual Meeting Proceedings (Abstract
, vol.280
-
-
Nikcevich, D.A.1
Grothey, A.2
Sloan, J.A.3
-
22
-
-
34147102323
-
Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients
-
Wang W.S., Lin J.K., Lin T.C., et al. Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist 12 (2007) 312-319
-
(2007)
Oncologist
, vol.12
, pp. 312-319
-
-
Wang, W.S.1
Lin, J.K.2
Lin, T.C.3
-
23
-
-
0037102328
-
Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial
-
Cascinu S., Catalano V., Cordella L., et al. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 20 (2002) 3478-3483
-
(2002)
J Clin Oncol
, vol.20
, pp. 3478-3483
-
-
Cascinu, S.1
Catalano, V.2
Cordella, L.3
-
24
-
-
0031158107
-
Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomized trial
-
Smyth J.F., Bowman A., Perren T., et al. Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomized trial. Ann Oncol 8 (1997) 569-573
-
(1997)
Ann Oncol
, vol.8
, pp. 569-573
-
-
Smyth, J.F.1
Bowman, A.2
Perren, T.3
-
25
-
-
0028815902
-
Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial
-
Cascinu S., Cordella L., Del Ferro E., et al. Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial. J Clin Oncol 13 (1995) 26-32
-
(1995)
J Clin Oncol
, vol.13
, pp. 26-32
-
-
Cascinu, S.1
Cordella, L.2
Del Ferro, E.3
-
26
-
-
33646464224
-
N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data
-
Lin P.C., Lee M.Y., Wang W.S., et al. N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data. Support Care Cancer 14 (2006) 484-487
-
(2006)
Support Care Cancer
, vol.14
, pp. 484-487
-
-
Lin, P.C.1
Lee, M.Y.2
Wang, W.S.3
-
27
-
-
33845915641
-
Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy
-
Argyriou A.A., Chroni E., Polychronopoulos P., et al. Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy. Neurology 67 (2006) 2253-2255
-
(2006)
Neurology
, vol.67
, pp. 2253-2255
-
-
Argyriou, A.A.1
Chroni, E.2
Polychronopoulos, P.3
-
28
-
-
33750904099
-
Randomized double blind (DB) placebo (Plcb) controlled phase III study assessing the efficacy of xaliproden (X) in reducing the cumulative peripheral sensory neuropathy (PSN) induced by the oxaliplatin (Ox) and 5-FU/LV combination (FOLFOX4) in first line treatment of patients (pts) with metastatic colorectal cancer (MCRC)
-
(abstract 229)
-
Cassidy J., Bjarnason G., Hickish T., et al. Randomized double blind (DB) placebo (Plcb) controlled phase III study assessing the efficacy of xaliproden (X) in reducing the cumulative peripheral sensory neuropathy (PSN) induced by the oxaliplatin (Ox) and 5-FU/LV combination (FOLFOX4) in first line treatment of patients (pts) with metastatic colorectal cancer (MCRC). J Clin Oncol 24 suppl (2006) 3507 (abstract 229)
-
(2006)
J Clin Oncol
, vol.24
, Issue.SUPPL
, pp. 3507
-
-
Cassidy, J.1
Bjarnason, G.2
Hickish, T.3
-
29
-
-
0036299151
-
Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy
-
Hammack J.E., Michalak J.C., Loprinzi C.L., et al. Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain 98 (2002) 195-203
-
(2002)
Pain
, vol.98
, pp. 195-203
-
-
Hammack, J.E.1
Michalak, J.C.2
Loprinzi, C.L.3
-
30
-
-
37349006917
-
Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms
-
Kautio A.L., Haanpää M., Saarto T., et al. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Symptom Manage 35 (2008) 31-39
-
(2008)
J Pain Symptom Manage
, vol.35
, pp. 31-39
-
-
Kautio, A.L.1
Haanpää, M.2
Saarto, T.3
-
31
-
-
35648929958
-
Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3)
-
Rao R.D., Michalak J.C., Sloan J.A., et al. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 110 (2007) 2110-2118
-
(2007)
Cancer
, vol.110
, pp. 2110-2118
-
-
Rao, R.D.1
Michalak, J.C.2
Sloan, J.A.3
-
32
-
-
46049110377
-
Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3
-
Rao R.D., Flynn P.J., Sloan J.A., et al. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer 112 (2008) 2802-2808
-
(2008)
Cancer
, vol.112
, pp. 2802-2808
-
-
Rao, R.D.1
Flynn, P.J.2
Sloan, J.A.3
-
33
-
-
21744443122
-
Clinical management of oxaliplatin-associated neurotoxicity
-
Grothey A. Clinical management of oxaliplatin-associated neurotoxicity. Clin Colorectal Cancer 1 suppl 5 (2005) S38-S46
-
(2005)
Clin Colorectal Cancer
, vol.1
, Issue.SUPPL. 5
-
-
Grothey, A.1
-
34
-
-
11444259306
-
Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial
-
Argyriou A.A., Chroni E., Koutras A., et al. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial. Neurology 64 (2005) 26-31
-
(2005)
Neurology
, vol.64
, pp. 26-31
-
-
Argyriou, A.A.1
Chroni, E.2
Koutras, A.3
-
35
-
-
3042523914
-
Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer
-
Gamelin L., Boisdron-Celle M., Delva R., et al. Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer. Clin Cancer Res 10 (2004) 4055-4061
-
(2004)
Clin Cancer Res
, vol.10
, pp. 4055-4061
-
-
Gamelin, L.1
Boisdron-Celle, M.2
Delva, R.3
-
36
-
-
34548544244
-
Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity
-
Hochster H.S., Grothey A., and Childs B.H. Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity. J Clin Oncol 25 (2007) 4028-4029
-
(2007)
J Clin Oncol
, vol.25
, pp. 4028-4029
-
-
Hochster, H.S.1
Grothey, A.2
Childs, B.H.3
-
37
-
-
33644843853
-
OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer-a GERCOR study
-
Tournigand C., Cervantes A., Figer A., et al. OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer-a GERCOR study. J Clin Oncol 24 (2006) 394-400
-
(2006)
J Clin Oncol
, vol.24
, pp. 394-400
-
-
Tournigand, C.1
Cervantes, A.2
Figer, A.3
-
38
-
-
35748943212
-
Pharmacologic management of neuropathic pain: evidence-based recommendations
-
Dworkin R.H., O'Connor A.B., Backonja M., et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132 (2007) 237-251
-
(2007)
Pain
, vol.132
, pp. 237-251
-
-
Dworkin, R.H.1
O'Connor, A.B.2
Backonja, M.3
-
39
-
-
0037468691
-
Oral opioid therapy for chronic peripheral and central neuropathic pain
-
Rowbotham M.C., Twilling L., Davies P.S., et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 348 (2003) 1223-1232
-
(2003)
N Engl J Med
, vol.348
, pp. 1223-1232
-
-
Rowbotham, M.C.1
Twilling, L.2
Davies, P.S.3
-
40
-
-
42349085789
-
Current developments in opioid therapy for management of cancer pain
-
de Leon-Casasola O.A. Current developments in opioid therapy for management of cancer pain. Clin J Pain 24 suppl 10 (2008) S3-S7
-
(2008)
Clin J Pain
, vol.24
, Issue.SUPPL. 10
-
-
de Leon-Casasola, O.A.1
-
41
-
-
3042595723
-
Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study
-
Gabrail N.Y., Dvergsten C., and Ahdieh H. Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study. Curr Med Res Opin 20 (2004) 911-918
-
(2004)
Curr Med Res Opin
, vol.20
, pp. 911-918
-
-
Gabrail, N.Y.1
Dvergsten, C.2
Ahdieh, H.3
-
42
-
-
48449090565
-
Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies
-
Xiao W., Naso L., and Bennett G.J. Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies. Pain Med 9 (2008) 505-517
-
(2008)
Pain Med
, vol.9
, pp. 505-517
-
-
Xiao, W.1
Naso, L.2
Bennett, G.J.3
-
44
-
-
56049123409
-
The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene
-
Waddell D.S., Baehr L.M., van den Brandt J., et al. The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. Am J Physiol Endocrinol Metab 295 (2008) E785-E797
-
(2008)
Am J Physiol Endocrinol Metab
, vol.295
-
-
Waddell, D.S.1
Baehr, L.M.2
van den Brandt, J.3
-
45
-
-
34548191071
-
Role of glucocorticoids in the molecular regulation of muscle wasting
-
Menconi M., Fareed M., O'Neal P., et al. Role of glucocorticoids in the molecular regulation of muscle wasting. Crit Care Med 35 suppl (2007) S602-S608
-
(2007)
Crit Care Med
, vol.35
, Issue.SUPPL
-
-
Menconi, M.1
Fareed, M.2
O'Neal, P.3
-
46
-
-
37249020448
-
Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer
-
Saif M.W., and Hashmi S. Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer. Cancer Chemother Pharmacol 61 (2008) 349-354
-
(2008)
Cancer Chemother Pharmacol
, vol.61
, pp. 349-354
-
-
Saif, M.W.1
Hashmi, S.2
-
47
-
-
33746158512
-
Risk of aplastic anemia in patients using antiepileptic drugs
-
Handoko K.B., Souverein P.C., van Staa T.P., et al. Risk of aplastic anemia in patients using antiepileptic drugs. Epilepsia 47 (2006) 1232-1236
-
(2006)
Epilepsia
, vol.47
, pp. 1232-1236
-
-
Handoko, K.B.1
Souverein, P.C.2
van Staa, T.P.3
-
48
-
-
53549124403
-
Hepatotoxicity associated with antiepileptic drugs
-
Bjornsson E. Hepatotoxicity associated with antiepileptic drugs. Acta Neurol Scand 118 (2008) 281-290
-
(2008)
Acta Neurol Scand
, vol.118
, pp. 281-290
-
-
Bjornsson, E.1
-
49
-
-
18844420343
-
Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy
-
Durand J.P., Alexandre J., Guillevin L., et al. Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy. Anticancer Drugs 16 (2005) 587-591
-
(2005)
Anticancer Drugs
, vol.16
, pp. 587-591
-
-
Durand, J.P.1
Alexandre, J.2
Guillevin, L.3
-
50
-
-
0037056091
-
Use of anticonvulsants for treatment of neuropathic pain
-
Backonja M.M. Use of anticonvulsants for treatment of neuropathic pain. Neurology 59 suppl 2 (2002) S14-S17
-
(2002)
Neurology
, vol.59
, Issue.SUPPL. 2
-
-
Backonja, M.M.1
-
51
-
-
0037318162
-
Antidepressants for chronic neuropathic pain
-
Reisner L. Antidepressants for chronic neuropathic pain. Curr Pain Headache Rep 7 (2003) 24-33
-
(2003)
Curr Pain Headache Rep
, vol.7
, pp. 24-33
-
-
Reisner, L.1
-
52
-
-
48449102484
-
Anticholinergic activity of 107 medications commonly used by older adults
-
Chew M.L., Mulsant B.H., Pollock B.G., et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc 56 (2008) 1333-1341
-
(2008)
J Am Geriatr Soc
, vol.56
, pp. 1333-1341
-
-
Chew, M.L.1
Mulsant, B.H.2
Pollock, B.G.3
-
53
-
-
35848958367
-
Antidepressant agents for the treatment of chronic pain and depression
-
Jann M.W., and Slade J.H. Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy 27 (2007) 1571-1587
-
(2007)
Pharmacotherapy
, vol.27
, pp. 1571-1587
-
-
Jann, M.W.1
Slade, J.H.2
-
54
-
-
33747303833
-
A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study
-
Nalamachu S., Crockett R.S., Gammaitoni A.R., et al. A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study. MedGenMed 8 (2006) 33-44
-
(2006)
MedGenMed
, vol.8
, pp. 33-44
-
-
Nalamachu, S.1
Crockett, R.S.2
Gammaitoni, A.R.3
-
55
-
-
0032954053
-
Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study
-
Galer B.S., Rowbotham M.C., Perander J., et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 80 (1999) 533-538
-
(1999)
Pain
, vol.80
, pp. 533-538
-
-
Galer, B.S.1
Rowbotham, M.C.2
Perander, J.3
-
56
-
-
2942532905
-
Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy
-
Barbano R.L., Herrmann D.N., Hart-Gouleau S., et al. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol 61 (2004) 914-918
-
(2004)
Arch Neurol
, vol.61
, pp. 914-918
-
-
Barbano, R.L.1
Herrmann, D.N.2
Hart-Gouleau, S.3
-
57
-
-
0034237501
-
Systemic lidocaine for neuropathic pain relief
-
Mao J., and Chen L.L. Systemic lidocaine for neuropathic pain relief. Pain 87 (2000) 7-17
-
(2000)
Pain
, vol.87
, pp. 7-17
-
-
Mao, J.1
Chen, L.L.2
|